The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Oxybutynin Hydrochloride 5mg/5ml Oral Solution

5 mg/5ml Oral solution

Syri Pharma Limited t/a Thame LaboratoriesPA22697/014/002

Main Information

Trade NameOxybutynin Hydrochloride 5mg/5ml Oral Solution
Active SubstancesOXYBUTYNIN HYDROCHLORIDE
Strength5 mg/5ml
Dosage FormOral solution
Licence HolderSyri Pharma Limited t/a Thame Laboratories
Licence NumberPA22697/014/002

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD04 oxybutynin

Status

Authorised/WithdrawnAuthorised
Licence Issued27/03/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsNo document available
Package LeafletNo document available
Public Assessment ReportNo document available
« Back